Exact Mass: 576.3903

Collettiside I

C33H52O8 (576.3662)

Diosgenin 3-O-beta-D-glucoside is a sterol 3-beta-D-glucoside having diosgenin as the sterol component. It has a role as a metabolite. It is a sterol 3-beta-D-glucoside, a monosaccharide derivative, a hexacyclic triterpenoid and a spiroketal. It is functionally related to a diosgenin. It derives from a hydride of a spirostan. Disogluside is a natural product found in Allium rotundum, Allium narcissiflorum, and other organisms with data available. Capsicoside A3 is found in herbs and spices. Capsicoside A3 is a constituent of Capsicum annuum roots. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2]. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2].

beta-Sitosterol 3-O-beta-D-galactopyranoside

C35H60O6 (576.439)

Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. beta-Sitosterol 3-O-beta-D-galactopyranoside is found in herbs and spices. beta-Sitosterol 3-O-beta-D-galactopyranoside is a constituent of Hibiscus sabdariffa (roselle) leaves. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178)

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial). [HMDB] 3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial).

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone

C38H56O4 (576.4178)

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114]. [HMDB] 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114].

Campesteryl ferulate

C38H56O4 (576.4178)

Campesteryl ferulate is found in cereals and cereal products. Campesteryl ferulate is a constituent of various cereal grains Constituent of various cereal grains

Schottenol 3-glucoside

C35H60O6 (576.439)

Constituent of citron-melon fruits (Citrullus lanatus variety citroides). Schottenol 3-glucoside is found in watermelon, fruits, and spinach. Schottenol 3-glucoside is found in fruits. Schottenol 3-glucoside is a constituent of citron-melon fruits (Citrullus lanatus var. citroides).

Etiopurpurin

C37H44N4O2 (576.3464)

PA(8:0/18:1(12Z)-O(9S,10R))

C29H53O9P (576.3427)

PA(8:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-O(9S,10R)/8:0)

C29H53O9P (576.3427)

PA(18:1(12Z)-O(9S,10R)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/8:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:1(9Z)-O(12,13))

C29H53O9P (576.3427)

PA(8:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(9Z)-O(12,13)/8:0)

C29H53O9P (576.3427)

PA(18:1(9Z)-O(12,13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/8:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

24-Methylcholesterol ferulate

C38H56O4 (576.4178)

24-methylcholesterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylcholesterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylcholesterol ferulate can be found in corn, which makes 24-methylcholesterol ferulate a potential biomarker for the consumption of this food product.

24-Methyllathosterol ferulate

C38H56O4 (576.4178)

24-methyllathosterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methyllathosterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methyllathosterol ferulate can be found in corn, which makes 24-methyllathosterol ferulate a potential biomarker for the consumption of this food product.

24-Methylenecholestanol ferulate

C38H56O4 (576.4178)

24-methylenecholestanol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylenecholestanol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylenecholestanol ferulate can be found in corn, which makes 24-methylenecholestanol ferulate a potential biomarker for the consumption of this food product.

MCULE-8628710105

C30H56O10 (576.3873)

Agosterol D2

C33H52O8 (576.3662)

(-)-Buxapapinolamine

C35H48N2O5 (576.3563)

Thorexanthin

C41H52O2 (576.3967)

Hippuristerone F

C33H52O8 (576.3662)

1,3-Diacetyl-24-epi-polacandrin

C34H56O7 (576.4026)

Agosterol A

C33H52O8 (576.3662)

Agosterol E

C33H52O8 (576.3662)

Agosterol G

C33H52O8 (576.3662)

3alpha-acetoxy-21S,25-dimethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin F

C34H56O7 (576.4026)

3alpha-acetoxy-21R-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S,25-triol|chisopanin G

C34H56O7 (576.4026)

SCHEMBL13641595

C38H48N4O (576.3828)

Methyl-2alpha-benzoyloxy-3beta-hydroxy-urs-12-en-28-oat

C37H52O5 (576.3815)

methyl musangate B

C33H52O8 (576.3662)

3alpha-hydroxy-28beta-methoxy-13alpha-ursan-28,12beta-epoxide 3-benzoate

C38H56O4 (576.4178)

Venturicidin X

C34H56O7 (576.4026)

O10-Buxafuranamine

C35H48N2O5 (576.3563)

3beta-hydroxy-27-benzoyloxylup-20(29)-en-28-oic acid

C37H52O5 (576.3815)

Raspacionin

C34H56O7 (576.4026)

C33H52O8

C33H52O8 (576.3662)

(24R)-ergost-5-en-11-oxo-3beta-ol-alpha-D-glucopyranoside|argyroside

C34H56O7 (576.4026)

O6-Buxafuranamine

C35H48N2O5 (576.3563)

nolinospiroside C

C33H52O8 (576.3662)

C34H56O7

C34H56O7 (576.4026)

4-O-acetyl-3-O-[beta-D-arabinopyranosyloxy]-cholest-5-ene-3beta,19-diol

C34H56O7 (576.4026)

methyl 3-beta-acetoxy-2alpha,11alpha,19alpha,28-tetrahydroxyurs-12-en-24-oate

C33H52O8 (576.3662)

agladoral E

C34H56O7 (576.4026)

ypsilanogenin

C33H52O8 (576.3662)

21,24-diacetoxylanostan-3,22,25-triol|terresterol

C34H56O7 (576.4026)

3beta-O-(alpha-L-fucopyranosyl)-11-hydroxy-24-methylene-9,11-secocholest-5-en-9-one|sinularoside A

C34H56O7 (576.4026)

(25S)-3-oxo-5alpha-spirostan-6alpha-yl-O-beta-D-xylopyranoside

C33H52O8 (576.3662)

10,10-Methylenebis(norvallesamidine)

C39H52N4 (576.4192)

30-(4-hydroxybenzoyloxy)-11alpha-hydroxylupane-20(29)-en-3-one

C37H52O5 (576.3815)

ruscogenin 3-O-alpha-L-rhamnopyranoside

C33H52O8 (576.3662)

24-methylenecholest-5-en-3beta,7beta,16beta-triol-3-O-alpha-L-fucoside|24-methylenecholest-5-ene-3beta,7beta,16beta-triol-3-O-alpha-L-fucopyranoside

C34H56O7 (576.4026)

Phomenolactone

C34H56O7 (576.4026)

cholest-8-ene-3beta,5alpha,6alpha,7alpha,10alpha-pentol 3,6,7-triacetate

C33H52O8 (576.3662)

24-methylenecholestanol ferulate

C38H56O4 (576.4178)

(24R,S)-24-methyllathosterol ferulate

C38H56O4 (576.4178)

(25S)-6alpha-hydroxy-5alpha-spirostan-3-one 6-O-(beta-D-quinovopyranoside)|solagenin 6-O-(beta-D-quinovopyranoside)

C33H52O8 (576.3662)

methyl musangate A

C33H52O8 (576.3662)

agosterol C6

C33H52O8 (576.3662)

Phe Val Arg Arg

C26H44N10O5 (576.3496)

Phe Lys Leu Arg

C28H48N8O5 (576.3747)

Ile Gly Lys Ile Phe

C29H48N6O6 (576.3635)

5-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-3-hydroxydecanoic acid

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid [IIN-based on: CCMSLIB00000848124]

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid [IIN-based: Match]

C30H56O10 (576.3873)

Phe Arg Arg Val

C26H44N10O5 (576.3496)

Phe Arg Val Arg

C26H44N10O5 (576.3496)

Arg Phe Arg Val

C26H44N10O5 (576.3496)

Arg Phe Val Arg

C26H44N10O5 (576.3496)

Arg Arg Phe Val

C26H44N10O5 (576.3496)

Arg Arg Val Phe

C26H44N10O5 (576.3496)

Arg Val Phe Arg

C26H44N10O5 (576.3496)

Arg Val Arg Phe

C26H44N10O5 (576.3496)

Val Phe Arg Arg

C26H44N10O5 (576.3496)

Val Arg Phe Arg

C26H44N10O5 (576.3496)

Val Arg Arg Phe

C26H44N10O5 (576.3496)

IGKIF

C29H48N6O6 (576.3635)

1-Hydroxyvitamin D3 3-D-glucopyranoside

C33H52O8 (576.3662)

D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

PA(12:0/15:1(9Z))

C30H57O8P (576.3791)

PA(13:0/14:1(9Z))

C30H57O8P (576.3791)

PA(14:1(9Z)/13:0)

C30H57O8P (576.3791)

PA(15:1(9Z)/12:0)

C30H57O8P (576.3791)

PA(P-16:0/12:0)

C31H61O7P (576.4155)

Campesteryl ferulate

C38H56O4 (576.4178)

Exophilin A1

C30H56O10 (576.3873)

PA 27:1

C30H57O8P (576.3791)

PA O-28:1

C31H61O7P (576.4155)

Superecdysone E

C33H52O8 (576.3662)

ST 27:2;O2;GlcA

C33H52O8 (576.3662)

Oryzanol

C38H56O4 (576.4178)

Bisdehydro-beta-carotene-2-carboxylic acid

C41H52O2 (576.3967)

Clathriaxanthin

C41H52O2 (576.3967)

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178)

Menabitan

C37H56N2O3 (576.4291)

Aluminum,tris(2,2,6,6-tetramethyl-3,5-heptanedionato-kO3,kO5)-, (OC-6-11)-

C33H57AlO6 (576.397)

N,N-dimethyl-4-[2-(1-octadecylpyridin-1-ium-2-yl)ethenyl]aniline,perchlorate

C33H53ClN2O4 (576.3694)

Collettiside I

C33H52O8 (576.3662)

Constituent of Trigonella foenum-graecum (fenugreek). Collettiside I is found in herbs and spices and fenugreek. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2]. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2].

3-Hydroxy-5-(3-hydroxy-5-(3,5-dihydroxydecanoyloxy)decanoyloxy)decanoic acid

C30H56O10 (576.3873)

(6R)-6-[(1R,3aS,4E,7aR)-4-{(2Z)-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyloctahydro-1H-inden-1-yl]-2-methylheptan-2-yl beta-D-glucopyranosiduronic acid

C33H52O8 (576.3662)

solasodine 3-O-beta-D-glucopyranoside

C33H54NO7+ (576.39)

Solasodine galactoside

C33H54NO7+ (576.39)

3-O-beta-D-glucosyl-diosgenin

C33H52O8 (576.3662)

Etiopurpurin

C37H44N4O2 (576.3464)

24-Methyllathosterol ferulate

C38H56O4 (576.4178)

PA(8:0/18:1(12Z)-O(9S,10R))

C29H53O9P (576.3427)

PA(18:1(12Z)-O(9S,10R)/8:0)

C29H53O9P (576.3427)

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C29H53O9P (576.3427)

[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C29H53O9P (576.3427)

[(3S,10R,13R,17R)-17-[(2R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)

2-(Hydroxymethyl)-6-(5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2-piperidin-1-ium]-16-yl)oxyoxane-3,4,5-triol

C33H54NO7+ (576.39)

2-[[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

(+)-Buxafuranamide

C35H48N2O5 (576.3563)

A natural product found in Buxus natalensis.

solasodine 3-beta-D-glucoside

C33H54NO7+ (576.39)

C35 phosphodolichol

C35H61O4P (576.4307)

3-[5-(3,5-Dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid

C30H56O10 (576.3873)

NAGlySer 16:4/11:0

C32H52N2O7 (576.3774)

2,3-dihydroxypropyl [2-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] hydrogen phosphate

C30H57O8P (576.3791)

Mgdg O-19:0_3:0

C31H60O9 (576.4237)

Mgdg O-9:0_13:0

C31H60O9 (576.4237)

Mgdg O-14:0_8:0

C31H60O9 (576.4237)

Mgdg O-18:0_4:0

C31H60O9 (576.4237)

Mgdg O-8:0_14:0

C31H60O9 (576.4237)

Mgdg O-13:0_9:0

C31H60O9 (576.4237)

Mgdg O-16:0_6:0

C31H60O9 (576.4237)

Mgdg O-17:0_5:0

C31H60O9 (576.4237)

Mgdg O-20:0_2:0

C31H60O9 (576.4237)

Mgdg O-15:0_7:0

C31H60O9 (576.4237)

Mgdg O-12:0_10:0

C31H60O9 (576.4237)

Mgdg O-11:0_11:0

C31H60O9 (576.4237)

Mgdg O-10:0_12:0

C31H60O9 (576.4237)

PE-Cer 14:1;2O/14:0

C30H61N2O6P (576.4267)

PE-Cer 13:1;2O/15:0

C30H61N2O6P (576.4267)

PE-Cer 12:1;2O/16:0

C30H61N2O6P (576.4267)

PE-Cer 15:1;2O/13:0

C30H61N2O6P (576.4267)

PE-Cer 13:0;2O/15:1

C30H61N2O6P (576.4267)

PE-Cer 15:0;2O/13:1

C30H61N2O6P (576.4267)

PE-Cer 16:1;2O/12:0

C30H61N2O6P (576.4267)

PE-Cer 14:0;2O/14:1

C30H61N2O6P (576.4267)

PE-Cer 12:0;2O/16:1

C30H61N2O6P (576.4267)

PE-Cer 15:1;2O/12:1;O

C29H57N2O7P (576.3903)

PE-Cer 14:2;2O/13:0;O

C29H57N2O7P (576.3903)

PE-Cer 15:2;2O/12:0;O

C29H57N2O7P (576.3903)

PE-Cer 12:2;2O/15:0;O

C29H57N2O7P (576.3903)

PE-Cer 12:1;2O/15:1;O

C29H57N2O7P (576.3903)

PE-Cer 14:1;2O/13:1;O

C29H57N2O7P (576.3903)

PE-Cer 13:1;2O/14:1;O

C29H57N2O7P (576.3903)

PE-Cer 13:2;2O/14:0;O

C29H57N2O7P (576.3903)

[(E)-2-acetamido-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(butanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(nonanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(hexadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(heptadecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(pentanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(hexanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(heptanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(octanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(propanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(decanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(dodecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

PEtOH 25:1

C30H57O8P (576.3791)

PMeOH 13:0_13:1

C30H57O8P (576.3791)

PMeOH 12:0_14:1

C30H57O8P (576.3791)

Fahfa 16:4/22:5

C38H56O4 (576.4178)

Fahfa 22:6/16:3

C38H56O4 (576.4178)

Fahfa 18:5/20:4

C38H56O4 (576.4178)

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

C30H56O10 (576.3873)

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate

C30H56O10 (576.3873)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate

C30H56O10 (576.3873)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate

C30H56O10 (576.3873)

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate

C30H56O10 (576.3873)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate

C30H56O10 (576.3873)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

C30H56O10 (576.3873)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate

C30H56O10 (576.3873)

[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate

C30H56O10 (576.3873)

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate

C30H57O8P (576.3791)

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate

C30H57O8P (576.3791)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate

C30H57O8P (576.3791)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-tetracos-13-enoate

C30H57O8P (576.3791)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-tetradec-9-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-hexadec-9-enoate

C30H57O8P (576.3791)

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetradecanoate

C30H57O8P (576.3791)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-pentadec-9-enoate

C30H57O8P (576.3791)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

C30H57O8P (576.3791)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H52O5 (576.3815)

N-(decanoyl)-4E-pentadecasphingenine-1-phosphocholine

C30H61N2O6P (576.4267)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-hexadec-7-enoate

C30H57O8P (576.3791)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C30H57O8P (576.3791)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-pentadec-9-enoate

C30H57O8P (576.3791)

[(E,2S,3R)-2-(decanoylamino)-3-hydroxypentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-pentadec-9-enoate

C30H57O8P (576.3791)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-hexadec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

C30H57O8P (576.3791)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] undecanoate

C30H56O10 (576.3873)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-tetradec-9-enoate

C30H57O8P (576.3791)

[1-carboxy-3-[2-hydroxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO6+ (576.4264)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C30H57O8P (576.3791)

2-[[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate

C30H56O10 (576.3873)

2-[[3-acetyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[2-butanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[1-carboxy-3-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C33H54NO7+ (576.39)

2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[[3-butanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

C33H54NO7+ (576.39)

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[[2-acetyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

Trillin

C33H52O8 (576.3662)

Diosgenin 3-O-beta-D-glucoside is a sterol 3-beta-D-glucoside having diosgenin as the sterol component. It has a role as a metabolite. It is a sterol 3-beta-D-glucoside, a monosaccharide derivative, a hexacyclic triterpenoid and a spiroketal. It is functionally related to a diosgenin. It derives from a hydride of a spirostan. Disogluside is a natural product found in Allium rotundum, Allium narcissiflorum, and other organisms with data available. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent A sterol 3-beta-D-glucoside having diosgenin as the sterol component. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2]. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2].

3-demethylubiquinone-6

C38H56O4 (576.4178)

A polyprenylbenzoquinone that is fumigatin which is substituted by an all-trans-hexaprenyl group at position 6.

C35-phosphodolichol

C35H61O4P (576.4307)

A dolichyl phosphate in which the dolichyl moiety contains six prenyl units

calcidiol 3-O-(beta-D-glucuronide)

C33H52O8 (576.3662)

A steroid glucosiduronic acid that is calcidiol in which the hydroxy hydrogen at position 3 has been replaced by a beta-D-glucuronyl residue.

1-dodecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C30H57O8P (576.3791)

1-tridecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C30H57O8P (576.3791)

1-(9Z-tetradecenoyl)-2-tridecanoyl-glycero-3-phosphate

C30H57O8P (576.3791)

1-(9Z-pentadecenoyl)-2-dodecanoyl-glycero-3-phosphate

C30H57O8P (576.3791)

calcidiol 25-O-(beta-D-glucuronide)

C33H52O8 (576.3662)

A steroid glucosiduronic acid that is calcidiol in which the hydroxy hydrogen at position 25 has been replaced by a beta-D-glucuronyl residue.

FAHFA 12:2/O-26:7

C38H56O4 (576.4178)

FAHFA 12:3/O-26:6

C38H56O4 (576.4178)

FAHFA 12:4/O-26:5

C38H56O4 (576.4178)

FAHFA 13:2/O-25:7

C38H56O4 (576.4178)

FAHFA 13:3/O-25:6

C38H56O4 (576.4178)

FAHFA 13:4/O-25:5

C38H56O4 (576.4178)

FAHFA 14:2/O-24:7

C38H56O4 (576.4178)

FAHFA 14:3/O-24:6

C38H56O4 (576.4178)

FAHFA 14:4/O-24:5

C38H56O4 (576.4178)

FAHFA 15:2/O-23:7

C38H56O4 (576.4178)

FAHFA 15:3/O-23:6

C38H56O4 (576.4178)

FAHFA 15:4/O-23:5

C38H56O4 (576.4178)

FAHFA 15:5/O-23:4

C38H56O4 (576.4178)

FAHFA 16:2/O-22:7

C38H56O4 (576.4178)

FAHFA 16:3/O-22:6

C38H56O4 (576.4178)

FAHFA 16:4/O-22:5

C38H56O4 (576.4178)

FAHFA 16:5/O-22:4

C38H56O4 (576.4178)

FAHFA 17:2/O-21:7

C38H56O4 (576.4178)

FAHFA 17:3/O-21:6

C38H56O4 (576.4178)

FAHFA 17:4/O-21:5

C38H56O4 (576.4178)

FAHFA 17:5/O-21:4

C38H56O4 (576.4178)

FAHFA 18:3/O-20:6

C38H56O4 (576.4178)

FAHFA 18:4/O-20:5

C38H56O4 (576.4178)

FAHFA 18:5/O-20:4

C38H56O4 (576.4178)

FAHFA 18:6/O-20:3

C38H56O4 (576.4178)

FAHFA 19:3/O-19:6

C38H56O4 (576.4178)

FAHFA 19:4/O-19:5

C38H56O4 (576.4178)

FAHFA 19:5/O-19:4

C38H56O4 (576.4178)

FAHFA 19:6/O-19:3

C38H56O4 (576.4178)

FAHFA 20:3/O-18:6

C38H56O4 (576.4178)

FAHFA 20:4/O-18:5

C38H56O4 (576.4178)

FAHFA 20:5/O-18:4

C38H56O4 (576.4178)

FAHFA 20:6/O-18:3

C38H56O4 (576.4178)

FAHFA 21:4/O-17:5

C38H56O4 (576.4178)

FAHFA 21:5/O-17:4

C38H56O4 (576.4178)

FAHFA 21:6/O-17:3

C38H56O4 (576.4178)

FAHFA 21:7/O-17:2

C38H56O4 (576.4178)

FAHFA 22:4/O-16:5

C38H56O4 (576.4178)

FAHFA 22:5/O-16:4

C38H56O4 (576.4178)

FAHFA 22:6/O-16:3

C38H56O4 (576.4178)

FAHFA 22:7/O-16:2

C38H56O4 (576.4178)

FAHFA 23:4/O-15:5

C38H56O4 (576.4178)

FAHFA 23:5/O-15:4

C38H56O4 (576.4178)

FAHFA 23:6/O-15:3

C38H56O4 (576.4178)

FAHFA 23:7/O-15:2

C38H56O4 (576.4178)

FAHFA 24:5/O-14:4

C38H56O4 (576.4178)

FAHFA 24:6/O-14:3

C38H56O4 (576.4178)

FAHFA 24:7/O-14:2

C38H56O4 (576.4178)

FAHFA 25:5/O-13:4

C38H56O4 (576.4178)

FAHFA 25:6/O-13:3

C38H56O4 (576.4178)

FAHFA 25:7/O-13:2

C38H56O4 (576.4178)

FAHFA 26:5/O-12:4

C38H56O4 (576.4178)

FAHFA 26:6/O-12:3

C38H56O4 (576.4178)

FAHFA 26:7/O-12:2

C38H56O4 (576.4178)

FAHFA 38:9;O

C38H56O4 (576.4178)

MGDG 10:0_11:0

C30H56O10 (576.3873)

MGDG 21:0

C30H56O10 (576.3873)

MGDG O-21:1;O

C30H56O10 (576.3873)

MGDG O-22:0

C31H60O9 (576.4237)

MGMG 22:0

C31H60O9 (576.4237)

DGGA 20:0

C29H52O11 (576.3509)

MGGA 21:0

C30H56O10 (576.3873)

PA O-14:0/14:1

C31H61O7P (576.4155)

PA O-14:1/14:0

C31H61O7P (576.4155)

PA O-16:0/11:2;O

C30H57O8P (576.3791)

PA O-16:1/12:0

C31H61O7P (576.4155)

PA O-18:0/8:3;O2

C29H53O9P (576.3427)

PA O-18:1/10:0

C31H61O7P (576.4155)

PA O-26:3;O2

C29H53O9P (576.3427)

PA O-27:2;O

C30H57O8P (576.3791)

PA P-14:0/14:0

C31H61O7P (576.4155)

PA P-14:0/14:0 or PA O-14:1/14:0

C31H61O7P (576.4155)

PA P-16:0/12:0

C31H61O7P (576.4155)

PA P-16:0/12:0 or PA O-16:1/12:0

C31H61O7P (576.4155)

PA P-18:0/10:0

C31H61O7P (576.4155)

PA P-18:0/10:0 or PA O-18:1/10:0

C31H61O7P (576.4155)

PA P-18:0/8:2;O2

C29H53O9P (576.3427)

PA P-18:0/9:1;O

C30H57O8P (576.3791)

PA P-18:1/8:1;O2

C29H53O9P (576.3427)

PA P-28:0

C31H61O7P (576.4155)

PA P-28:0 or PA O-28:1

C31H61O7P (576.4155)

PA 18:1/8:1;O

C29H53O9P (576.3427)

PA 20:0/6:2;O

C29H53O9P (576.3427)

PA 22:1/4:1;O

C29H53O9P (576.3427)

PA 26:2;O

C29H53O9P (576.3427)

PA 10:0_17:1

C30H57O8P (576.3791)

PA 11:0_16:1

C30H57O8P (576.3791)

PA 12:0_15:1

C30H57O8P (576.3791)

PA 13:0_14:1

C30H57O8P (576.3791)

PA 23:0/4:1

C30H57O8P (576.3791)

LPEth 26:1

C31H61O7P (576.4155)

LPM 27:1

C31H61O7P (576.4155)

PEth 24:2;O

C29H53O9P (576.3427)

PEth 25:1

C30H57O8P (576.3791)

PM 25:2;O

C29H53O9P (576.3427)

PM 26:1

C30H57O8P (576.3791)

Hexaprenylmethylhydroxymethoxybenzoquinone

C38H56O4 (576.4178)

CerPE 14:0;O2/14:1

C30H61N2O6P (576.4267)

CerPE 14:1;O2/14:0

C30H61N2O6P (576.4267)

CerPE 14:2;O2/13:0;O

C29H57N2O7P (576.3903)

CerPE 15:1;O2/13:0

C30H61N2O6P (576.4267)

CerPE 15:2;O2/12:0;O

C29H57N2O7P (576.3903)

CerPE 16:1;O2/12:0

C30H61N2O6P (576.4267)

CerPE 16:2;O2/11:0;O

C29H57N2O7P (576.3903)

CerPE 17:1;O2/11:0

C30H61N2O6P (576.4267)

CerPE 17:2;O2/10:0;O

C29H57N2O7P (576.3903)

CerPE 18:1;O2/10:0

C30H61N2O6P (576.4267)

CerPE 27:2;O2;O

C29H57N2O7P (576.3903)

CerPE 28:1;O2

C30H61N2O6P (576.4267)

SM 14:1;O2/11:0

C30H61N2O6P (576.4267)

SM 14:2;O2/10:0;O

C29H57N2O7P (576.3903)

SM 15:1;O2/10:0

C30H61N2O6P (576.4267)

SM 24:2;O2;O

C29H57N2O7P (576.3903)

SM 25:1;O2

C30H61N2O6P (576.4267)

Hydroxyvitamin D3 glucoside

C33H52O8 (576.3662)

ST 28:1;O;GlcA

C34H56O7 (576.4026)

ST 27:3;O3;Hex

C33H52O8 (576.3662)

ST 28:2;O2;Hex

C34H56O7 (576.4026)

(4r,6r)-4-hydroxy-6-[(1e,4r,5e,8r,9e,11s,12r,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-[(2r,4s,6s)-2,4,6-trimethyloctylidene]hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

7-(acetyloxy)-11-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4026)

4-hydroxy-6-[(1e,5e,9e,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

n-[(1s,3r,4s,6r,7s,8r,13s,16s,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,14-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

n-[(1s,6r,7s,8r,10s,11r,13s,14r,15s,16s)-8-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

n-[6-(acetyloxy)-7-[1-(dimethylamino)ethyl]-15-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,13-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

1-{11a-[(acetyloxy)methyl]-2-hydroxy-3',9a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-4-hydroxy-2,3,4-trimethylpentyl acetate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

(6r)-6-methoxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C41H52O2 (576.3967)

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-10-(acetyloxy)-3,9-dibutoxy-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl acetate

C33H52O8 (576.3662)

2-[(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n,4-dimethylpentanamido}-1-hydroxy-4-methylpentylidene)amino]-3-methylbutanoic acid

C28H53ClN4O6 (576.3653)

methyl 3-(acetyloxy)-2,12,14-trihydroxy-8a-(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylate

C33H52O8 (576.3662)

[(1s,4r,12r,16s,17s)-17-hydroxy-12-methyl-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5(9),6,10-trien-17-yl]methyl (9z,12z)-octadeca-9,12-dienoate

C38H56O4 (576.4178)

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy}oxane-3,4,5-triol

C33H52O8 (576.3662)

(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

methyl (1r,2s,4ar,4bs,5s,6as,9r,10r,10as,12as)-5,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

methyl (1r,2s,4ar,4bs,6as,7s,9r,10r,10as,12ar)-7,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

6-{[9a-(hydroxymethyl)-11a-methyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4026)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-10-(acetyloxy)-1,9-dibutoxy-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12'r,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4e,6e,9z)-3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]pyran-2-one

C33H52O8 (576.3662)

[7-(acetyloxy)-8,9-dihydroxy-1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4026)

4-hydroxy-6-[4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

(1s,4r,5r,8r,10r,13r,14r,16r,17s,18s,19s,20r,23r)-23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

C38H56O4 (576.4178)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(3r,5ar,6r,7s,9ar)-6-{2-[(3r,5ar,6s,9ar)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

(3r,5r)-3-{[(3r,5r)-5-{[(3r,5r)-3,5-dihydroxydecanoyl]oxy}-3-hydroxydecanoyl]oxy}-5-hydroxydecanoic acid

C30H56O10 (576.3873)

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-11a-[(acetyloxy)methyl]-2-hydroxy-3',9a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-hydroxy-2,3,4-trimethylpentyl acetate

C33H52O8 (576.3662)

(3r,5r,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-(acetyloxy)-2,5-dihydroxy-2-methylheptan-3-yl acetate

C34H56O7 (576.4026)

(3s,5as,6s,7r,9as)-6-{2-[(3s,5as,6r,9as)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

n-[8-(acetyloxy)-7-[1-(dimethylamino)ethyl]-13-hydroxy-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

n-[(6s,7r,8r,9s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7-formyl-9-hydroxy-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

n-[(1r,3r,4s,6r,7s,8r,13s,16s,17r,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,14-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

1-(5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4026)

(1r,3as,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2s,2'r,4'r,5s,7'r,8's,9's,12's,13'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

4-hydroxy-1-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

6-methoxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C41H52O2 (576.3967)

5-({5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl}oxy)-3-hydroxydecanoic acid

C30H56O10 (576.3873)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

C38H56O4 (576.4178)

(2r,3r,4s,5r,6r)-2-methyl-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

methyl (2r,3r,4s,4ar,6ar,6bs,8as,11r,12r,12as,14r,14ar,14bs)-3-(acetyloxy)-2,12,14-trihydroxy-8a-(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylate

C33H52O8 (576.3662)

[(1r,3ar,3br,5ar,6r,7r,8r,9r,9ar,9bs,11ar)-7-(acetyloxy)-8,9-dihydroxy-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

methyl 5,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-(3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl)pyran-2-one

C33H52O8 (576.3662)

3-(acetyloxy)-6-[2-(3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl)ethyl]-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

(1s,3ar,3br,5as,7r,9r,9ar,9bs,11r,11ar)-7-(acetyloxy)-11-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4026)

methyl 7,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-5,6-dihydro-2',20'-dioxaspiro[pyran-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaen-3'-one

C36H48O6 (576.3451)

(1's,2s,5s,6r,10'z,12'z,14's,15's,16'z,19'r)-6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-5,6-dihydro-2',20'-dioxaspiro[pyran-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaen-3'-one

C36H48O6 (576.3451)

2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-hydroxy-6-methoxy-3-methylcyclohexa-2,5-diene-1,4-dione

C38H56O4 (576.4178)

(3e,5e,11e,13e)-16-[4-(6-ethyl-2-hydroxy-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C34H56O7 (576.4026)

12-ethyl-6-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-3-ol

C38H48N4O (576.3828)

(1r,9r,12r,19r)-12-ethyl-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-3-ol

C38H48N4O (576.3828)

7-(acetyloxy)-2,5-dihydroxy-6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-3-yl acetate

C34H56O7 (576.4026)

n-[(1s,3r,4s,6r,7s,8r,15r,16r,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-15-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,13-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

2-methyl-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy}oxane-3,4,5-triol

C33H52O8 (576.3662)

(3r,4s,5s,6s)-6-{[(1r,3as,3bs,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4026)

(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-5a-[(benzoyloxy)methyl]-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C37H52O5 (576.3815)

(3r,5r)-5-{[(3r,5r)-5-{[(3r,5r)-3,5-dihydroxydecanoyl]oxy}-3-hydroxydecanoyl]oxy}-3-hydroxydecanoic acid

C30H56O10 (576.3873)